Satellite Symposium:
Confronting the Burden of CMV in Transplant Recipients: Approaches for Management and Tackling Resistant Disease (Not Official IDWeek Programming - This activity is supported by an independent medical educational grant from Shire.- See Affiliated Events Guide)
Wednesday, October 26, 2016: 10:30 AM-1:00 PM
Room: 278-282

Learning Objectives:

All Satellite Symposia, Presentation Theaters, and Learning Lounges preceding and following the official program IDWeek 2016 are independently organized and executed.  IDWeek does not endorse or support the programming of any Symposia, Presentation Theater, or Learning Lounge.

Faculty:

Atul Humar, MD (Chair)

Director, Multi-Organ Transplant Program

University Health Network, Toronto, ON

 

Michael Boeckh, MD, PhD

Member

Fred Hutchinson Cancer Research Center

Professor

University of Washington, Seattle, WA

 

Sunwen Chou, MD

Professor of Medicine

Oregon Health & Science University, Portland, OR

 

Camille Nelson Kotton, MD, FIDSA, FAST

Clinical Director, Transplant and Immunocompromised Host Infectious Diseases

Massachusetts General Hospital

Associate Professor

Harvard Medical School

Past Chair, Infectious Disease Community of Practice, American Society of Transplantation, Boston, MA

 

Program Objectives:

This activity has been designed to meet the educational needs of clinicians who manage transplant patients with cytomegalovirus.

 

After completing this activity, the participant should be better able to:

  • Outline the burden of CMV viremia in SOT and HSCT patients including unmet needs for improved therapies

  • Describe the mechanisms and clinical implications of CMV drug resistance and refractory CMV disease

  • Summarize clinical trial data for emerging antiviral therapies

  • Integrate existing and emerging antiviral therapies into the treatment of CMV infection and/or disease in SOT and HSCT patients

 

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and RMEI Medical Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

 

Credit Designation:

The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

 

Agenda subject to change and was provided by:

RMEI Medical Education, LLC; 101 Laurel Road, Suite, 200; Voorhees, NJ; Phone: 856-672-3300; Fax: 856-546-7030

Please contact Stephanie Kielt directly at skielt@rmei.com for more information.

Target Audience: Clinicians

Presentations:
10:30 AM
Registration
11:00 AM
Welcome and Introductions (Dr. Humar)
11:10 AM
The Burden of CMV Disease in Transplant Patients (Dr. Humar)
11:25 AM
Mechanisms of Refractory and Resistant CMV (Dr. Chou)
11:50 AM
Case Challenge: Treating CMV Disease in HSCT (Dr. Boeckh)
12:15 PM
Case Challenge: Treating CMV Disease in SOT (Dr. Kotton)
12:40 PM
Q&A and Discussion (All faculty)

CME Credits: No CME credit is offered for this session.

ACPE Credits:

ACPE Number:


See more of: Satellite Symposium

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.